APOA1 and cardiovascular disorder: Multiple adverse health outcomes have been linked to low apoA1 levels, high apoB levels and high apoB/apoA1 ratios, leading to interest in developing strategies to manage abnormal apo variables for the prevention or treatment of associated metabolic and cardiovascular diseases.